These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Response by Wiberg et al to Letter Regarding Article, "Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest: A Randomized Controlled Trial". Wiberg S, Hassager C, Kjaergaard J. Circulation; 2017 May 16; 135(20):e1044-e1045. PubMed ID: 28507255 [No Abstract] [Full Text] [Related]
25. Impact of mean arterial pressure on clinical outcomes in comatose survivors of out-of-hospital cardiac arrest: Insights from the University of Ottawa Heart Institute Regional Cardiac Arrest Registry (CAPITAL-CARe). Russo JJ, James TE, Hibbert B, Yousef A, Osborne C, Wells GA, Froeschl MP, So DY, Chong AY, Labinaz M, Glover CA, Marquis JF, Dick A, Bernick J, Le May MR. Resuscitation; 2017 Apr 16; 113():27-32. PubMed ID: 28109998 [Abstract] [Full Text] [Related]
36. Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial. Smits MM, Tonneijck L, Muskiet MH, Hoekstra T, Kramer MH, Diamant M, van Raalte DH. Eur J Endocrinol; 2017 Jan 16; 176(1):77-86. PubMed ID: 27777261 [Abstract] [Full Text] [Related]
37. Targeted temperature management at 33°C versus 36°C and impact on systemic vascular resistance and myocardial function after out-of-hospital cardiac arrest: a sub-study of the Target Temperature Management Trial. Bro-Jeppesen J, Hassager C, Wanscher M, Østergaard M, Nielsen N, Erlinge D, Friberg H, Køber L, Kjaergaard J. Circ Cardiovasc Interv; 2014 Oct 16; 7(5):663-72. PubMed ID: 25270900 [Abstract] [Full Text] [Related]